CMS Submits Part D and Medicare Advantage Drug Pricing Proposal to Office…
We previously wrote about the proposed rule released by the United States Centers for Medicare and Medicaid Services (CMS) for…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
October 2018
CMS Releases Proposed CY20 Medicare Advantage/Part D Rule
Recently, the Centers for Medicare & Medicaid Services (CMS) released their Contract Year (CY) 2020 Medicare Advantage and…
HHS Unveils New Plan for Prescription Prices for Medicare Part B Drugs
On Thursday, October 25, 2018, the United States Department of Health and Human Services (HHS) and the Centers for Medicare &…
Second Letter from OPDP Issued Regarding the Bad Ad Campaign
We recently wrote about the Warning Letter MannKind Corporation received from the Office of Prescription Drug Promotion (OPDP) of…
Upcoming Webinar on Open Payment Data Trends
On October 30th, 2018, qordata will be hosting a webinar, “Examine Trends Over Four Full Years of Open Payments Data.”
With…
MannKind Corporation Receives Warning Letter from Facebook Post
On October 5, 2018, the Office of Prescription Drug Promotion (OPDP) of the United States Food and Drug Administration (FDA)…
FDA Releases Set of Guidances on Transdermal and Topical Delivery Systems
The Food and Drug Administration (FDA) released a pair of guidance documents intended to advance the development of generic drugs…
FDA Publishes Guidance on Product Identifiers Under the Drug Supply Chain…
In September, FDA published “Product Identifiers Under the Drug Supply Chain Security Act: Questions and Answers Guidance for…
PTAC Recommendations Seemingly Being Ignored
The Physician-Focused Payment Model Technical Advisory Committee (PTAC), established by Congress to recommend new physician…
HHS Proposes New DTC Advertising Requirement
For our daily readers, you may have seen our post yesterday about the Pharmaceutical and Research Manufacturers of America (PhRMA)…